New Challenges for ACE-Inhibitors in Vascular Diseases

ISSN： 1567-2697

Source： Drug Design Reviews - Online, Vol.2, Iss.7, 2005-11, pp. : 485-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The COREPA approach to lead generation: an application to ACE-inhibitors

By Kamenska V. Ivanov J. Mekenyan O.

European Journal of Medicinal Chemistry, Vol. 34, Iss. 9, 1999-09 ,pp. : 687-699

Elsevier

Access to resources Recommend Favorite

The Use of ACE‐Inhibitors after Myocardial Infarction

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. : 232-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4385-4413

Bentham Science Publishers

Access to resources Recommend Favorite

The Current Role of ACE-inhibitors for Secondary Prevention in Cardiovascular Disease; from Pathogenesis to Clinical Practice

By Voors Adriaan A. Veldhuisen Dirk J. Gilst Wiek H.

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 1, 2006-02 ,pp. : 69-73

Springer Publishing Company

Access to resources Recommend Favorite

ACE inhibitors, ARBs prevent new-onset atrial fibrillation

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite